Queen Mary University of London

Erratum to: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (Nature Communications, (2018), 9, 1, (3707), 10.1038/s41467-018-04989-w) (2019) Went M, Sud A, Foersti A, Halvarsson BM, Weinhold N, Kimber S, Van Duin M, et al. Journal article, Erratum Independent Left Ventricular Morphometric Atlases Show Consistent Relationships with Cardiovascular Risk Factors: A UK Biobank Study (2019) Gilbert K, Bai W, Mauger C, Medrano-Gracia P, Suinesiaputra A, Lee AM, Sanghvi MM, et al. Journal article Cassava Metabolomics and Starch Quality (2019) Rosado-Souza L, David LC, Drapal M, Fraser PD, Hofmann J, Klemens PA, Ludewig F, et al. Journal article KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) (2019) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, et al. Conference contribution Long-term disease stability assessed by the expanded disability status scale in patients treated with Cladribine tablets in the CLARITY and CLARITY extension studies (2019) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Vermersch P, Dangond F, Keller B, Jack D Conference contribution Introduction to the Issue on Signal Processing Advances for Non-Orthogonal Multiple Access in Next Generation Wireless Networks (2019) Liu Y, Ding Z, Al-Dhahir N, Schober R, Dobre OA, Karagiannidis GK, Fan P Journal article, Editorial Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy (2019) Heide T, Maurer A, Eipel M, Knoll K, Geelvink M, Veeck J, Knuechel R, et al. Journal article Introduction to the Issue on Signal Processing Advances for Non-Orthogonal Multiple Access in Next Generation Wireless Networks (2019) Liu Y, Ding Z, Al-Dhahir N, Schober R, Dobre OA, Karagiannidis GK, Fan P Journal article Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study (2019) Giovannoni G, Sorensen PS, Cook S, Rammohan KW, Rieckmann P, Comi G, Dangond F, et al. Journal article Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis (2019) Comi G, Cook S, Giovannoni G, Rieckmann P, Sorensen PS, Vermersch P, Galazka A, et al. Journal article